Inhibition of apoptosis-inducing factor translocation is involved in protective effects of hepatocyte growth factor against excitotoxic cell death in cultured hippocampal neurons-Reference-Cited by-同舟云学术

Inhibition of apoptosis-inducing factor translocation is involved in protective effects of hepatocyte growth factor against excitotoxic cell death in cultured hippocampal neurons

Published:2005-08-31 Issue:5 Volume:95 Page:1277-1286
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:

Author:

Ishihara Naoko,Takagi Norio,Niimura Makiko,Takagi Keiko,Nakano Midori,Tanonaka Kouichi,Funakoshi Hiroshi,Matsumoto Kunio,Nakamura Toshikazu,Takeo Satoshi

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1471-4159.2005.03446.x/fullpdf

Reference48 articles.

1. Expression of HGF and cMet in the developing and adult brain;Achim;Brain Res. Dev. Brain Res.,1997

2. Hepatocyte growth factor and the kidney: it is not just for the liver;Balkovetz;Int. Rev. Cytol.,1999

3. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product;Bottaro;Science,1991

4. Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons;Budd;Proc. Natl Acad. Sci. USA,2000

5. Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death?;Cande;J. Cell Sci.,2002

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase 1/2a, open label study to evaluate the safety and efficacy of a plasmid DNA encoding human hepatocyte growth factor in patients with Charcot-Marie-Tooth disease 1A;2024-06-14

2. Fosgonimeton, a Novel Positive Modulator of the HGF/MET System, Promotes Neurotrophic and Procognitive Effects in Models of Dementia;Neurotherapeutics;2022-12-20

3. HGF and MET: From Brain Development to Neurological Disorders;Frontiers in Cell and Developmental Biology;2021-06-09

4. Mitochondrial AIF loss causes metabolic reprogramming, caspase-independent cell death blockade, embryonic lethality, and perinatal hydrocephalus;Molecular Metabolism;2020-10

5. Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives;Critical Reviews in Oncology/Hematology;2018-03